We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Noninvasive Blood Glucose Test Evaluated for Accuracy

By LabMedica International staff writers
Posted on 23 Oct 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma. More...
Optical monitoring of blood glucose levels for non-invasive diagnosis is growing.

Recent efforts in this direction have been inclined towards reducing the requirement of calibration framework. Scientists have evaluated the accuracy of new technology to monitor blood glucose levels without needles or a finger prick. Early results show that the noninvasive technology measures blood glucose levels as effectively as a finger prick test without drawing blood.

A team of scientists from the Massachusetts Institute of Technology (Cambridge, MA, USA) and the University of Missouri-Columbia (Columbia, MO, USA) measured the blood glucose levels of 20 healthy, non-diabetic adults prior to drinking a glucose-rich beverage. Blood glucose levels were then measured in intervals over the next 160 minutes using three methods: spectroscopy, intra-venous blood test and finger prick. The tests are designed to determine how much glucose remains in the blood and if a patient's insulin-regulating mechanisms are working effectively. They found that spectroscopy predicted glucose values as accurately as a finger prick test.

The device uses a technique called Raman spectroscopy to measure the chemical composition of skin and extract the amount of glucose out of other skin compartments. A fiber optic cable attached to a wristband passes laser light onto the skin to detect different components in the skin, such as fat tissue, protein, collagen and glucose molecules. The shifts in wavelengths associated with glucose present in the blood create a sort of molecular fingerprint that can be used to determine glucose levels.

Jeon Woong Kang, PhD, a lead co-author of the study said, “We know that handheld skin prick tests are not always accurate and may be uncomfortable for patients. The gold standard is intravenous blood testing, but frequent blood draws may not be an option for many patients. We were pleased to find that our initial results show Raman spectroscopy can measure glucose levels that are comparable to the finger stick devices. We hope that we can refine this method to be a noninvasive continuous glucose monitoring sensor.” The study was published in the October 2018 issue of the journal Analytical and Bioanalytical Chemistry.

Related Links:
Massachusetts Institute of Technology
University of Missouri-Columbia


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.